One World Products (One World Products) Risk Assessment

View and export this data going back to 2015. Start your Free Trial

What is One World Products Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of One World Products is: No Data: Cannot be evaluated.

Competitive Comparison of One World Products's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, One World Products's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

One World Products's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, One World Products's Risk Assessment distribution charts can be found below:

* The bar in red indicates where One World Products's Risk Assessment falls into.

One World Products (OTCPK:OWPC) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

One World Products Risk Assessment Related Terms

Thank you for viewing the detailed overview of One World Products's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

One World Products (One World Products) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » One World Products Inc (OTCPK:OWPC) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

6605 Grand Montecito Parkway, Suite 100, Las Vegas, NV, USA, 89118

Website

https://oneworldproducts.com

One World Products Inc along with its subsidiaries is engaged in the cultivation, production, and distribution of raw cannabis and hemp plant ingredients for both medical and industrial uses. It focuses on cultivating, processing, and supplying cannabis oil, distillate, and isolate to customer's specifications.

Executives

Sommer Joerg Herman Walter	officer: President	RHEINSTR. 50, BONN 2M 53179
Terry Lynn Buffalo	director	3063 BRIGHTON BLVD, #918, DENVER CO 80216
Timothy Woods	officer: Chief Financial Officer	8191 QUINN TERRACE, VIENNA VA 22180
Vahe Gabriel	officer: CFO and COO	808 BRICKELL KEY DRIVE, APT. # 1106, MIAMI FL 33131
Isiah Iii Thomas	director, officer: CEO and Vice Chairman	TWO PENNSYLVANIA PLAZA, NEW YORK NY 10121
Bruce I Raben	director	430 VICTORIA TERRACE, RIDGEFIELD NJ 7657
Craig Ellins	director, officer: CEO and CFO	3035 EAST PATRICK LANE, SUITE 9, LAS VEGAS NV 89120
Lei Wang	director, 10 percent owner, officer: CEO & CFO	2609 MONTE CRESTA DRIVE, BELMONT CA 94002